Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2016-10-12 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Touch Surgery releases Episealer® surgical knee simulations in collaboration with Episurf Medical
Regulatory Filings Classification · 95% confidence The document is a 'Company Announcement' dated October 12, 2016, detailing a collaboration between Touch Surgery and Episurf Medical regarding the release of a surgical simulation. It describes a partnership and a product release, not a standard periodic financial report (like 10-K, IR, ER) or a formal regulatory filing like a Director's Dealing or Major Shareholding notification. The final paragraph states: 'This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation.' This strongly suggests it is a mandatory disclosure under EU regulations, which often fall under general regulatory announcements or RNS (Regulatory News Service) in many jurisdictions, especially when the content is operational/partnership news rather than financial results or governance changes. Since it doesn't fit the specific categories like DIV, CAP, MANG, or DIRS, and it is a general public disclosure mandated by regulation, the most appropriate fallback is Regulatory Filings (RNS). The document length is short (3523 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA is not applicable.
2016-10-12 English
Touch Surgery lanserar simuleringar för Episealer® knäoperation i samarbete med Episurf Medical
Environmental & Social Information Classification · 99% confidence The document is a press release dated October 12, 2016, announcing a collaboration between Episurf Medical and Touch Surgery to launch a simulation tool for Episealer knee surgery. It details a business partnership and product launch, not a mandatory financial filing like a 10-K, IR, or ER. It is an announcement regarding a business development/partnership. Since there is no specific category for 'Business Partnership Announcement' or 'Product Launch Announcement' among the provided codes, and it is a general public announcement, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general regulatory announcement/miscellaneous filing category for non-standard reports, although 'RPA' (Report Publication Announcement) is sometimes used for announcements, this is more of a news release about an event/partnership rather than announcing the publication of a formal report itself. Given the nature of the content (a press release about a strategic collaboration), RNS is the best fit as a general regulatory/public disclosure announcement.
2016-10-12 Swedish
Change in number of shares and votes in Episurf Medical
Share Issue/Capital Change Classification · 98% confidence The document is a short company announcement dated September 30, 2016, detailing a change in the number of shares and votes due to conversions between Class A and Class B shares. This directly relates to a change in the company's capital structure (share count). This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes in share count, splits, or capital structure changes. It is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). Since it is a specific announcement about share structure change, SHA is the most appropriate code over the general 'RNS'. The document length is short (1696 chars), but it contains the substantive information itself, not just an announcement of another report, thus avoiding the RPA classification.
2016-09-30 English
Förändring av antalet aktier och röster i Episurf Medical
Share Issue/Capital Change Classification · 98% confidence The document is a press release dated September 30, 2016, titled "Förändring av antalet aktier och röster i Episurf Medical" (Change in the number of shares and votes in Episurf Medical). It explicitly details the conversion of A-shares to B-shares, resulting in a change in the total number of shares (15,949,804) and total votes (22,813,418). This directly relates to changes in the company's capital structure or share count. Based on the definitions, this fits best under 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, or potentially 'Capital/Financing Update' (CAP). Since it is a direct notification of a change in the number of shares outstanding due to conversions, SHA is the most precise fit. The final sentence confirms it is information the company is obliged to disclose regarding financial instruments.
2016-09-30 Swedish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage by a specific holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') in the issuer ('Episurf Medical AB'). It explicitly states the 'Reason for major shareholding notification Buy' and provides the 'Before' and 'After the transaction' details, including the new percentage (5.01% directly held shares, 3.5% voting rights). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2016-09-29 English
Episurf Medical’s implant technology further supported by the presentation of 12-month clinical data at the highly regarded ICRS congress in Sorrento, Italy
Regulatory Filings Classification · 99% confidence The document is a 'Company Announcement' dated September 26, 2016, detailing the presentation of 12-month clinical data for the Episealer implant at the ICRS congress. It focuses on scientific findings, quotes the CEO, and includes contact information and an 'About' section. Crucially, the final paragraph states: 'This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation.' This structure—a brief announcement about an event or data release, often mandated by regulation, and not a full financial report (like 10-K or IR) or a transcript—fits best under the general 'Regulatory Filings' category (RNS) or potentially an Investor Presentation (IP) if it were the presentation itself. Since this is an announcement *about* data being presented at a congress, and it is short (3773 chars), it functions as a general regulatory disclosure or news release that doesn't fit the more specific financial or governance codes. Therefore, RNS (Regulatory Filings) is the most appropriate fallback.
2016-09-26 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.